GlassScriptPhysician profile
John Andrew Kaufman
NPI 1992711584
$29,179.33
in general payments reported to CMS, 2019-2025
10 companies · $74.32 in 2025
The $74.32 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,076 · 2020: $3,650 · 2021: $4,151 · 2022: $5,307 · 2023: $12K · 2025: $74.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Consulting Fee: $1,220 · Food and Beverage: $378 · Travel and Lodging: $27.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,370.00 |
| Consulting Fee | $1,220.00 |
| Food and Beverage | $377.89 |
| Travel and Lodging | $27.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $20,026.91 | 2020-2023 | Gunther Tulip, Cook, Rosch-Uchida |
| Shape Memory Medical INC. | $4,079.08 | 2019-2020 | |
| Canon Medical Systems USA, INC. | $1,445.82 | 2019 | |
| Covidien LP | $1,397.65 | 2019 | |
| Cook Medical LLC | $1,231.39 | 2019-2025 | Profusion Therapeutic Infusion Needle, Zilver Ptx, Rosch-Uchida |
| Bayer Healthcare Pharmaceuticals INC. | $876.00 | 2021 | |
| Bolton Medical INC | $95.27 | 2023 | Treo Abdominal Stent-Graft System |
| Biocompatibles, INC. | $27.21 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$15,300.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.